Silicon Laboratories Inc.
SLAB
$145.85
$4.463.15%
NASDAQ
| 10/04/2025 | 07/05/2025 | 04/05/2025 | 12/28/2024 | 09/28/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.10% | 29.66% | 2.16% | -25.29% | -47.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.10% | 29.66% | 2.16% | -25.29% | -47.00% |
| Cost of Revenue | 37.05% | 27.87% | 7.42% | -15.38% | -36.88% |
| Gross Profit | 56.13% | 31.17% | -1.91% | -32.22% | -53.67% |
| SG&A Expenses | 15.56% | 18.22% | 13.18% | -1.05% | -10.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.31% | 14.93% | 6.64% | -7.01% | -18.73% |
| Operating Income | 54.32% | 32.59% | -34.59% | -585.15% | -387.51% |
| Income Before Tax | 61.12% | 42.37% | -20.22% | -482.60% | -350.00% |
| Income Tax Expenses | -87.87% | -81.97% | 19,833.85% | 355.71% | -9.22% |
| Earnings from Continuing Operations | 63.69% | 47.20% | -57.09% | -453.40% | -490.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 63.69% | 47.20% | -57.09% | -453.40% | -490.84% |
| EBIT | 54.32% | 32.59% | -34.59% | -585.15% | -387.51% |
| EBITDA | 66.04% | 41.43% | -75.40% | -534.16% | -229.22% |
| EPS Basic | 64.29% | 47.97% | -55.38% | -449.38% | -492.01% |
| Normalized Basic EPS | 61.80% | 43.28% | -18.88% | -480.22% | -350.30% |
| EPS Diluted | 64.26% | 48.00% | -54.32% | -424.32% | -506.41% |
| Normalized Diluted EPS | 61.80% | 43.32% | -17.69% | -435.54% | -358.73% |
| Average Basic Shares Outstanding | 1.72% | 1.72% | 1.69% | 1.22% | 0.22% |
| Average Diluted Shares Outstanding | 1.72% | 1.50% | 0.43% | -1.41% | -2.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |